Chemoprevention of Prostate Cancer-Reference-Cited by-同舟云学术

Chemoprevention of Prostate Cancer

Published:2009-08 Issue:2 Volume:182 Page:499-508
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Thompson Ian M.¹,Tangen Catherine M.¹,Goodman Phyllis J.¹,Lucia M. Scott¹,Klein Eric A.¹

Affiliation:

1. Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, the Fred Hutchinson Cancer Research Center, Seattle, Washington, the Department of Pathology, University of Colorado Health Science Center, Denver, Colorado, and the Glickman Urology and Kidney Institute, The Cleveland Clinic, Cleveland, Ohio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference54 articles.

1. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey;Eisenberg;JAMA,1998

2. Probabilities of eventually developing or dying of cancer–United States, 1985;Seidman;CA Cancer J Clin,1985

3. Cancer statistics 2008;Jemal;CA Cancer J Clin,2008

4. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control;Weir;J Natl Cancer Inst,2003

5. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?;Sirovich;JAMA,2003

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between dihydrotestosterone and long‐term risk for prostate cancer mortality: A prospective cohort study;The Prostate;2020-05-05

2. Association of finasteride with prostate cancer;Medicine;2020-04

3. Influence of Postoperative Finasteride Therapy on Recurrence of Gynecomastia After Mastectomy in Men Taking Finasteride for Alopecia;American Journal of Men's Health;2019-09-25

4. Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride;Cancer Prevention Research;2018-12-11

5. Safety concerns when using novel medications to treat alopecia;Expert Opinion on Drug Safety;2018-10-25